ARCHIVES

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

President Sppointed John Niederhuber NCI Director.

September 8, 2006

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

“The Working Group urges NCI to reconsider its current budget to determine whether the 25 percent devoted to the IRP is appropriate.”

July 7, 1995

New CCOP RFA To Encourage Cancer Control Research; Larger But Fewer Awards Are Likely

May 9, 1986

Study Finds Relationship Between Meat Intake, Cancer

August 27, 2010

Biology Societies Recomend 15% Funding Increase for NIH

February 12, 1999